Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue and Scrap for the year ending 31-Mar-2022.
Hot Stocks: Brokerages on Syngene, Home First Finance and Devyani International
Brokerage CLSA maintained a buy rating on Syngene International while Motilal Oswal initiated coverage on Home First Finance with a buy call. Furthermore, Sharekhan initiated a buy on Devyani International.
Biocon sells 5.4 pc stake in arm Syngene International
The scrip of Syngene International has settled 2.38 per cent lower at Rs 565 apiece on the BSE.ICICI Prudential Mutual Fund was among the entities that lapped up the company's shares.As of June year, of the promoters' holding of 70.29 per cent, Biocon held a 69.99 per cent stake in Syngene, the shareholding pattern with the exchange showed
I hope you're doing well & enjoying highly volatile markets. Yesterday was one such day in which market wiped out all the Gap Down loss in 1st 30 Min Candle, almost lost every gain and again gained to close near highs. 🫣
SYNGENE - Daily Chart, bullish momentum can be seen above 580 (trendline breakout) till 640 and next resistance comes around 680, Close price 574.90 (Disclaimer - this is for education purpose only)
Jonathan Hunt on growth triggers which led to upgrade of Syngene sales guidance
“ Syngene has signed a 10-year strategic deal with Zoetis in animal health: It was a real piece of innovation from Zoetis and we are delighted to sign the deal which is a strategic one and is in the biologics manufacturing part of the organisation. They should get going with that set up starting this year and then we will start to see it in the P&L much more strongly from next year. It starts the rebalancing of the organisation.”
Stocks in the news: Wipro, HUL, Grasim, Vedanta, HDFC Life and telcos
Wipro, Havells, IndusInd Bank, Gland Pharma, Tata Communications, Oracle Financial, Syngene International, Century Plyboards, Mastek and Ceat are among the companies that will announce their earnings for the quarter ended June 2022.
Corporate Radar: Bajaj Auto, Biocon to turn ex-dividend; MMTC Q4 earnings, HDFC AGM & more
Shares of DU Digital Global and Paisalo Digital will go ex-split today. DU Digital Global had announced the splitting of shares into face value of Rs 2 from the face value of Rs 10 while Paisalo Digital had announced the splitting of shares into face value of Re 1 from the face value of Rs 10.
Global brokerages see up to 115% upside in Tata Steel, Vedanta, Gland Pharma
The brokerage believes that weakness in China's export prices will dent the company, leading to an EBITDA cut by 32-34 per cent on the back of lower realizations.
Syngene International skids 4% as Q4 PAT declines 8% YoY
On a standalone basis, the companys quarterly net profit stood at Rs 147 crore in March 2022, down 8.41 per cent from Rs 160.50 crore in March 2021. Net sales clocked in at Rs 758.70 crore in March 2022, up 15.29 per cent from Rs 658.10 crore in March 2021, reports said.
Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.
Day Trading Guide: 2 stock recommendations for Tuesday
A rally in the Bank Nifty found stiff resistance near its 50-day EMA. Selling pressure intensified as intraday recoveries remained short-lived, and eventually Bank Nifty settled below the 37,000 mark. Sustenance below 37,500 is expected to keep Bank Nifty under pressure.